Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The increased use of mammography and introduction of breast screening programmes have resulted in a rise in clinically-occult breast cancer, with one-third of all breast carcinomata diagnosed being non-palpable. These types of cancer have a unique natural history and biology compared to symptomatic breast cancer and this needs to be taken into account when considering surgery and adjuvant treatment. The majority of studies demonstrating efficacy of adjuvant treatments are largely based on patients with symptomatic breast cancer. The current evidence for the role of surgery and adjuvant therapy for screen-detected breast cancer was reviewed in light of their improved prognosis, compared to symptomatic breast cancer.

Type

Journal article

Journal

Anticancer Res

Publication Date

03/2014

Volume

34

Pages

1141 - 1146

Keywords

Adjuvant, adjuvant chemotherapy, adjuvant endocrine, adjuvant radiotherapy, breast cancer, review, screening, Breast Neoplasms, Female, Humans, Mammography, Mass Screening, Prognosis